Advance Search
SUN Wenyan, QIU Jing, SHAO Yunlei. Analysis in risk factors of central lymph node metastasis in patients with minimal papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 87-89. DOI: 10.7619/jcmp.20200401
Citation: SUN Wenyan, QIU Jing, SHAO Yunlei. Analysis in risk factors of central lymph node metastasis in patients with minimal papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(2): 87-89. DOI: 10.7619/jcmp.20200401
shu

Analysis in risk factors of central lymph node metastasis in patients with minimal papillary thyroid carcinoma

  • Nankang District First People′s Hospital in Ganzhou City in Jiangxi Province, Ganzhou, Jiangxi, 341400

More Information
  • Received Date: November 14, 2020
  • Available Online: January 26, 2021
  • Published Date: January 27, 2021
    Graphical Abstract
    • Abstract
  •   Objective  To analyze the risk factors of central lymph node metastasis in patients with papillary thyroid carcinoma (PTMC) and their pathological features.
      Methods  The data of 178 patients with PTMC were analyzed retrospectively. The pathological characteristics of the patients were summerized. The risk factors of central lymph node metastasis were analyzed by Logistic regression model.
      Results  The rate of central lymph node metastasis in 178 PTMC patients was 30.9%(55/178). Single factor analysis showed that central lymphatic metastasis was closely related to below 45 years of age, the largest tumor diameter more than 5 mm, combining with capsule invasion, multiple lesions, bilateral cancer lesions (P < 0.05 or P < 0.01), while had no correlations with gender and whether combining with lymphocytic thyroiditis or not (P>0.05). Multivariate analysis showed that below 45 years of age, maximum tumor diameter more than 5 mm, multiple cancer foci, bilateral cancer foci, and complicating envelop were independent risk factors for central lymph node metastasis in PTMC patients (P < 0.01).
      Conclusion  The risk factors of central lymph node metastasis include below 45 years of age, the largest tumor diameter more than 5 mm, multiple cancer foci, bilateral cancer foci, and complicating envelop. Therefore, it is recommended to actively perform lymph node dissection in central region for prevention.
    • FullText(HTML)
    • References (17)
  • [1]
    赵铁铮, 任意, 王玉文. 甲状腺乳头状癌患者临床病理特征及中央区淋巴结转移危险因素分析[J]. 中国医药, 2019, 14(3): 77-79. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYG201903018.htm
    [2]
    沈文亮, 吕晶, 黑虎, 等. cN0期甲状腺微小乳头状癌侧颈淋巴结转移危险因素分析[J]. 中国普通外科杂志, 2019, 28(5): 551-557. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201905008.htm
    [3]
    曾书娥, 于姣姣, 耿霞飞. 甲状腺微小乳头状癌的超声特征与中央区淋巴结转移的危险因素分析[J]. 中国中西医结合影像学杂志, 2019, 17(5): 78-78. https://www.cnki.com.cn/Article/CJFDTOTAL-JHYX201905018.htm
    [4]
    王朝晖, 张悦嘉, 伏桂明, 等. 甲状腺微小乳头状癌中央区淋巴转移的危险因素分析[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(1): 12-17. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201603002.htm
    [5]
    王猛, 魏玺, 郑向前, 等. 甲状腺微小乳头状癌临床病理特征与中央区淋巴结转移的相关性探讨[J]. 天津医科大学学报, 2018, 12(12): 181-181. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYK201802011.htm
    [6]
    王岩岩, 李莉, 彭德峰, 等. 甲状腺微小乳头状癌中央区淋巴结转移的相关因素分析[J]. 中华全科医学, 2018, 16(8): 1268-1270, 1282. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201808014.htm
    [7]
    于淏, 王强, 查斯洛, 等. 5 mm及以下cN0甲状腺乳头状微小癌中央区淋巴结转移规律及危险因素分析[J]. 第二军医大学学报, 2018, 39(1): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201801018.htm
    [8]
    马小开, 黄建康, 彭德峰, 等. 228例甲状腺微小乳头状癌临床特征及颈部淋巴结转移危险因素分析[J]. 中国癌症杂志, 2019, 29(8): 590-594. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGAZ201908006.htm
    [9]
    刘文, 程若川, 苏艳军, 等. 甲状腺乳头状癌中央区淋巴结转移危险因素研究(附3273例回顾性分析)[J]. 中国实用外科杂志, 2018, 38(3): 316-321. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201803024.htm
    [10]
    陈立权, 庞士勇, 丁士海, 等. 甲状腺微小乳头状癌颈淋巴结转移危险因素分析及外科处理策略[J]. 安徽医药, 2020, 24(5): 144-147. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYY202005037.htm
    [11]
    庄欢, 杨帆, 廉猛, 等. 甲状腺微小乳头状癌颈部中央区淋巴结转移的相关危险因素分析[J]. 国际耳鼻咽喉头颈外科杂志, 2020, 44(1): 16-19. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201701015.htm
    [12]
    刘晓芳, 徐琨, 黄晓春, 等. 高频超声结合造影特征对甲状腺微小乳头状癌颈部淋巴结转移的预测价值[J]. 中华全科医师杂志, 2020, 19(7): 612-617.
    [13]
    王良, 梁万明, 罗晓勇. 甲状腺微小乳头状癌中央区淋巴结转移的危险因素分析[J]. 中国现代普通外科进展, 2018, 21(2): 102-105. https://www.cnki.com.cn/Article/CJFDTOTAL-PWJZ201802006.htm
    [14]
    郑香玉, 李博. 甲状腺微小乳头状癌中央区淋巴结转移的相关危险因素分析[J]. 中国民康医学, 2018, 30(5): 98-99. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMYX201805049.htm
    [15]
    孙振华, 赵志泓, 蒋华平. 甲状腺微小乳头状癌rⅥb区淋巴结转移因素分析及术中纳米碳应用价值研究[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(4): 355-359. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202004017.htm
    [16]
    马亚辉, 刘宜翔, 易国华, 等. cN0期甲状腺微小乳头状癌颈侧区淋巴结转移的危险因素及预防性清扫的临床分析[J]. 国际外科学杂志, 2019, 46(4): 242-246. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI202001004.htm
    [17]
    张成雷. 可手术乳腺癌患者的循环肿瘤细胞与凝血功能及病理特征的关系研究[J]. 中国医学创新, 2019, 14(19): 1-5. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCX201919018.htm
    • Related Articles

  • Cited by

    Periodical cited type(4)

    1. 张丽，靳辉. 腕踝针联合Bobath疗法治疗脑卒中上肢运动功能障碍的研究. 湖北中医药大学学报. 2023(03): 98-100 .
    2. 燕炼钢，周婷，贾泽坤，杨娅，江娜，何彦蓉，王储蓄，殷红彪. 针刺阳明经配合补阳还五汤加减治疗气虚血瘀型脑梗死的效果分析. 实用临床医药杂志. 2023(22): 105-109 . 本站查看
    3. 徐瑾，陈新旺，李莉莉. 醒脑开窍针刺疗法联合补阳还五汤加味治疗气虚血瘀型脑梗死恢复期患者的临床效果. 慢性病学杂志. 2022(03): 420-422 .
    4. 陈俊，熊义涛，何俊，张腾. 脑脉通颗粒结合奥拉西坦治疗脑卒中后恢复期(气虚血瘀证)疗效及对认知功能及运动功能影响研究. 中华中医药学刊. 2022(09): 63-66 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (219) PDF downloads (18) Cited by(7)
    Turn off MathJax
    Article Contents
    Abstract
    References

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return